No Data
No Data
Nikkei average contribution ranking (advance closing) ~ The Nikkei Average rebounded, and TOEREC boosted by about 61 yen with 1 brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 26 days ago was 121 stocks with a price increase and 101 stocks with a price drop of 3 stocks unchanged. The Nikkei Average rebounded. The front-end transaction was closed at 37780.35 yen (estimated volume of 740 million shares), which was 151.87 yen higher (+0.40%) compared to the previous day. The US stock market declined on the 25th. The Dow average depreciated by 375.12 dollars (-0.98%) at 38085.80 dollars, and the NASDAQ depreciated 100.99 points (-0.64%) at 15611.
ADR Japan Stock Ranking ~ Komatsu etc. have a general sales advantage, Chicago is 55 yen higher than Osaka's 37,665 yen ~
Japanese ADR (American Depositary Securities) stocks fell in comparison with the Tokyo Stock Exchange (converted to 1 dollar 155.58 yen), Komatsu <6301>, AGC <5201>, Isuzu <7202>, ANA <9202>, Hishijisho <8802>, Sumitomo Electric <5802>, SECOM <9735>, etc. fell, and overall sales were dominant. The Chicago Nikkei 225 futures settlement price is 37,665 yen, 55 yen higher than the Osaka daytime. The US stock market declined. The Dow average depreciated by $375.12 to $38,085.80, and the NASDAQ
Brands that moved the day before part 2 Sakura Gome, Smart Value, Chugai Pharmaceutical, etc.
<コード>Stock name closing price on the 25th ⇒ compared to the previous day Pana HD <6752> 1325 -68 earnings forecasts were revised downward centered on transient factors. CyberAgent <4751> 976.5 -58.5 The first half of the year's positive financial results were also exhausted, and the feeling prevailed. GURUNAVI <2440> broke through the 302-1325 line and had an advantage in closeout sales. Chugai Pharmaceutical<4519> 4860-291 saw a drastic decrease in sales for the first quarter. Hino Motors <7205> 462.6 -29.325 financial results
It's worth collecting! The yen exchange rate fell below 155, and stocks are expected to usher in investment opportunities these days
Dama believes that in a scenario where the yen is weak for a long time, the strong US economy will continue to be driven by overseas demand, and that the performance of companies driven by external demand will outperform those related to domestic demand in Japan.
Meta Water, Canon, Avionics, etc.
<4519> Chugai Pharmaceutical 4860-291 continued to decline drastically. Financial results for the first quarter were announced the day before. Core operating income was 102.1 billion yen, down 3.1% from the same period last year, but market consensus has improved due to a cost ratio decline higher than expected. However, sales revenue declined drastically, with a 24.1% decrease from the same period. In addition to the decline in sales due to the completion of deliveries to the Rona Grove government, Babysmo, Alesensa, etc. also fell short of expectations, and overseas shipments of Actemra also seem to have declined due to the effects of biosimilars. sluggish
Front market [stocks that have moved, stocks that have been created]
*Japan Aviation Electronics Industry<6807> 2548 +217 The profit forecast for the current fiscal year exceeds market expectations. *Ordinary income forecasts were revised upward due to large vacuum <6962> 827 +44 exchange margin recording, etc. *Are Capcom <9697> 2636 +73.5 evoJapan upcoming events also expected. *Is it a supply-demand factor, such as buybacks in the high price range of NIPPATS <5991> 1584 +44? *Eisai <4523> No. 6244 +155 Alzheimer's drug “Rekenbi”
No Data